OUTPUT
LIVE

Serial Number

97617393

Owner

Jingu Health Inc.

Attorney

Trina A. Longo

Filing Date

Oct 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

OUTPUT Trademark

Serial Number: 97617393

OUTPUT is a trademark filed by Jingu Health Inc. on October 3, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Jingu Health Inc.

41 Union Square West, Suite 1428
New York, NY 10003

Entity Type: 03

OUTPUT BIOSCIENCES INC.

41 UNION SQUARE WEST, SUITE 1428
NEW YORK, NY 10003

Entity Type: 03

Trademark Details

Filing Date

October 3, 2022

Registration Date

Not Registered

Goods & Services

Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for preventing or treating diseases in a human subject, using targeted bioactives for the modulation of disturbed microbial ecosystems; Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for preventing or treating diseases in a human subject, via targeted modulation of a host microbial community; Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for the prevention and treatment of human diseases, namely, Autoimmune diseases and disorders, Bone and joint diseases and disorders, Cancer, Cardiovascular diseases and disorders, Gastro-intestinal diseases and disorders, Hematologic diseases and disorders, Infectious diseases and disorders, Kidney diseases and disorders, Lung diseases and disorders, Metabolic diseases and disorders, Muscle diseases and disorders, Nephrology diseases and disorders, Neurodegenerative diseases and disorders, Neurological diseases and disorders, Ophthalmic diseases and disorders, Dermatological diseases and disorders, Inflammatory diseases and disorders, Immune disorders, Allergic disorders, Immuno-oncology and improving therapy outcome of Immuno-oncology therapies, Psychiatric diseases and disorders, Digestive diseases and disorders, Nutritional diseases and disorders, Malnutrition, Vaginal and penile diseases and disorders, Dysbioses, Fertility

Computational biology platform for preventative therapies and nutraceuticals, namely non-downloadable software in the field of computational biology for use in the discovery, design, and optimization of therapeutics, pharmaceuticals, preventative therapies, and nutraceuticals; Computational biology platform for preventative therapies and nutraceuticals, namely, non-downloadable software in the field of computational biology for use in the research, development, and identification of disease mechanisms and therapeutic targets within the human microbiome; Computational biology platform for preventative therapies and nutraceuticals, namely, non-downloadable software in the field of computational biology for use in designing, forecasting results, running, and monitoring clinical trials, and selecting clinical trial participants, all related to clinical trials for therapeutics, pharmaceuticals, preventative therapies and nutraceuticals; Product development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents, and nutraceuticals; research and development of therapeutics related to preventative therapies, pharmaceuticals, and nutraceuticals

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 6, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 6, 2026 XELR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 6, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 6, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 6, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 6, 2026 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 7, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 7, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 7, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 23, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 23, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 25, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 31, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 31, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 24, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 24, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 18, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 3, 2023 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2022 NWOS